RESUMO
The dysregulation of cyclin D -Cyclin-dependent kinase 4/6 (CDK4/6)-Rb axis has been implicated in breast cancer progression and the selective CDK4/6 inhibitors have shown effective activity in advanced breast cancer, especially in tumors driven by the estrogen receptor (ER). However, resistance to these small molecular inhibitors has become an inevitable clinical issue after their initial use. Here, we investigated the potential mechanism of resistance by establishing a CDK4/6 inhibitor palbociclib-resistant breast cancer cell line (MCF-7pR). After prolonged exposure to palbociclib, we detected the loss of the ER signaling and an increase in androgen receptor (AR). Moreover, we demonstrated more localization of AR in the cell nucleus of MCF-7pR compared to the parental cell (MCF-7). We also reported that AR could promote the progression of the cell cycle. Blockade of AR signaling could reduce the level of the relative G1-S cyclins, abolish Rb phosphorylation and inhibit the activation of transcriptional programs in S phase. Furthermore, dual inhibition of AR and CDK4/6 could reverse the resistance of palbociclib both in vitro and in vivo. In sum, our studies provide evidence that AR activation promotes cell cycle progression and cell proliferation in CDK4/6 inhibitor resistance, and identify AR inhibition as a putative novel therapeutic strategy to treat CDK4/6 inhibitor resistance in cancer.
Assuntos
Neoplasias da Mama/metabolismo , Ciclo Celular/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Quinase 4 Dependente de Ciclina/metabolismo , Quinase 6 Dependente de Ciclina/metabolismo , Piperazinas/farmacologia , Piridinas/farmacologia , Receptores Androgênicos/isolamento & purificação , Animais , Benzamidas , Western Blotting , Quinase 4 Dependente de Ciclina/genética , Quinase 6 Dependente de Ciclina/genética , Feminino , Humanos , Imuno-Histoquímica , Imunoprecipitação , Células MCF-7 , Camundongos , Nitrilas , Feniltioidantoína/análogos & derivados , Feniltioidantoína/farmacologia , Receptores Androgênicos/genéticaRESUMO
The paradigm of molecular histopathology is shifting from a single-marker immunohistochemistry towards multiplexed detection of markers to better understand the complex pathological processes. However, there are no systems allowing multiplexed IHC (mIHC) with high-resolution whole-slide tissue imaging and analysis, yet providing feasible throughput for routine use. We present an mIHC platform combining fluorescent and chromogenic staining with automated whole-slide imaging and integrated whole-slide image analysis, enabling simultaneous detection of six protein markers and nuclei, and automatic quantification and classification of hundreds of thousands of cells in situ in formalin-fixed paraffin-embedded tissues. In the first proof-of-concept, we detected immune cells at cell-level resolution (n = 128,894 cells) in human prostate cancer, and analysed T cell subpopulations in different tumour compartments (epithelium vs. stroma). In the second proof-of-concept, we demonstrated an automatic classification of epithelial cell populations (n = 83,558) and glands (benign vs. cancer) in prostate cancer with simultaneous analysis of androgen receptor (AR) and alpha-methylacyl-CoA (AMACR) expression at cell-level resolution. We conclude that the open-source combination of 8-plex mIHC detection, whole-slide image acquisition and analysis provides a robust tool allowing quantitative, spatially resolved whole-slide tissue cytometry directly in formalin-fixed human tumour tissues for improved characterization of histology and the tumour microenvironment.
Assuntos
Separação Celular/métodos , Imuno-Histoquímica/métodos , Neoplasias da Próstata/genética , Receptores Androgênicos/isolamento & purificação , Biomarcadores Tumorais/genética , Biomarcadores Tumorais/isolamento & purificação , Humanos , Processamento de Imagem Assistida por Computador , Masculino , Neoplasias da Próstata/diagnóstico , Neoplasias da Próstata/patologia , Receptores Androgênicos/genética , Microambiente Tumoral/genéticaAssuntos
Neoplasias de Próstata Resistentes à Castração/sangue , Receptores Androgênicos/sangue , Humanos , Masculino , Isoformas de Proteínas/sangue , RNA Mensageiro/sangue , RNA Mensageiro/isolamento & purificação , Receptores Androgênicos/genética , Receptores Androgênicos/isolamento & purificação , Manejo de Espécimes/métodosRESUMO
The strength of the streptavidin/biotin interaction poses challenges for the recovery of biotinylated molecules from streptavidin resins. As an alternative to high-temperature elution in urea-containing buffers, we show that mono-biotinylated proteins can be released with relatively gentle heating in the presence of biotin and 2% SDS/Rapigest, avoiding protein carbamylation and minimizing streptavidin dissociation. We demonstrate the utility of this mild elution strategy in two studies of the human androgen receptor (AR). In the first, in which formaldehyde cross-linked complexes are analyzed in yeast, a mass spectrometry-based comparison of the AR complex using SILAC reveals an association between the androgen-activated AR and the Hsp90 chaperonin, while Hsp70 chaperonins associate specifically with the unliganded complex. In the second study, the endogenous AR is quantified in the LNCaP cell line by absolute SILAC and MRM-MS showing approximately 127,000 AR copies per cell, substantially more than previously measured using radioligand binding.
Assuntos
Biotina/isolamento & purificação , Cromatografia de Afinidade/métodos , Receptores Androgênicos/isolamento & purificação , Estreptavidina/química , Sequência de Aminoácidos , Biotina/metabolismo , Biotinilação , Linhagem Celular Tumoral , Humanos , Espectrometria de Massas/normas , Dados de Sequência Molecular , Fragmentos de Peptídeos/química , Ligação Proteica , Mapeamento de Interação de Proteínas/métodos , Proteômica , Receptores Androgênicos/biossíntese , Receptores Androgênicos/metabolismo , Proteínas Recombinantes de Fusão/biossíntese , Proteínas Recombinantes de Fusão/isolamento & purificação , Proteínas Recombinantes de Fusão/metabolismo , Padrões de Referência , Saccharomyces cerevisiaeRESUMO
Evaluating endocrine activities of environmental chemicals or screening for new small molecule modulators of the androgen receptor (AR) transcription activity requires standardized and reliable assay procedures. Scintillation proximity assays (SPA) are sensitive and reliable techniques that are suitable for ligand competition binding assays. We have utilized a radiolabeled ligand competition binding assay for the androgen receptor (AR) that can be carried out in a 384-well format. This standardized, highly reproducible and low-cost assay has been automated for high-throughput screening (HTS) purposes.
Assuntos
Ensaio Radioligante/métodos , Receptores Androgênicos/metabolismo , Ligação Competitiva , Escherichia coli/genética , Escherichia coli/metabolismo , Humanos , Ligantes , Masculino , Receptores Androgênicos/genética , Receptores Androgênicos/isolamento & purificação , Proteínas Recombinantes/genética , Proteínas Recombinantes/isolamento & purificação , Proteínas Recombinantes/metabolismoRESUMO
The recruitment of co-repressors to the androgen receptor is an important mechanism for reducing androgen-mediated gene activation. Importantly, co-repressors play a major role in the treatment of hormone-dependent growing tissue, such as prostate cancer and breast cancer. In line with this, co-repressor dysfunction seems to be a major player for development of castration-resistant prostate cancer or therapy-resistant breast cancer. The molecular basis of hormone therapy by particular antihormones (antagonists) for the androgen receptor (AR) is mediated by enhanced recruitment and activity of co-repressors that cause repression of AR target genes that regulate proliferation and alteration of cancer cells. Therefore co-repressor recruitment is a crucial molecular mechanism of gene repression as well as inhibition of cancer growth. Here we describe different strategies to investigate co-repressor recruitment to the AR. First, we developed a modified mammalian two-hybrid system to investigate the recruitment of co-repressors to the AR within mammalian cells. This assay is very useful for the identification of the molecular mechanism of new AR antagonists and for molecular analysis of castration-resistant prostate cancer expressing the AR. Second, we describe a technique to analyze the interaction of AR isolated from human prostate cancer cells with a newly generated AR-specific co-repressor peptide, which is bacterially expressed and affinity purified by glutathione-S-transferase affinity precipitation assays in vitro. In summary, these methods can greatly facilitate the study of AR-co-repressor interactions.
Assuntos
Proteínas Correpressoras/metabolismo , Receptores Androgênicos/metabolismo , Técnicas de Cultura de Células , Proteínas Correpressoras/genética , Proteínas Correpressoras/isolamento & purificação , Escherichia coli/genética , Escherichia coli/metabolismo , Vetores Genéticos , Humanos , Imunoprecipitação , Ligantes , Receptores Androgênicos/genética , Receptores Androgênicos/isolamento & purificação , Proteínas Recombinantes de Fusão/genética , Proteínas Recombinantes de Fusão/isolamento & purificação , Proteínas Recombinantes de Fusão/metabolismo , Técnicas do Sistema de Duplo-HíbridoRESUMO
The androgen receptor (AR) is a DNA-binding and hormone-activated transcription factor that plays critical roles in the development and progression of prostate cancer. The transcriptional function of AR is modulated by intermolecular interactions with DNA elements and coactivator proteins, as well as intramolecular interactions between AR domains; thus, the structural information from the full-length AR or a multi-domain fragment is essential for understanding the molecular basis of AR functions. Here we report the expression and purification of full-length AR protein and of a fragment containing its DNA-binding and ligand-binding domains connected by the hinge region in the presence of its natural ligand, dihydrotestosterone. Crystals of ligand-bound full-length AR and of the AR fragment in complex with DNA elements and coactivator motifs have been obtained and diffracted to low resolutions. These results help establish a foundation for pursuing further crystallographic studies of an AR/DNA complex.
Assuntos
Cristalografia por Raios X/métodos , DNA/metabolismo , Receptores Androgênicos/química , Receptores Androgênicos/isolamento & purificação , Transativadores/metabolismo , Sequência de Aminoácidos , Bioensaio , Cristalização , Humanos , Masculino , Dados de Sequência Molecular , Peptídeos/química , Ligação Proteica , Estrutura Terciária de Proteína , Receptores Androgênicos/metabolismo , Alinhamento de Sequência , Transativadores/químicaRESUMO
OBJECTIVE: Mutation within androgen receptor (AR) can be seen. Presently, prediction of protein nanostructure and function is a great challenge in the proteomics and structural genomics era. To identify the points vulnerable to mutation is a new trend to expand the knowledge on disorders in genomic and proteomic level of diseases. DESIGN: The author performed a bioinformatics analysis to study the determined positions that correspond with peptide motifs in the amino acid sequence of AR. INTERVENTION(S): To identify the weak linkages in AR, a new bioinformatics tool, GlobPlot, was used. MAIN OUTCOME MEASURE(S): Mutation-sensitive points. RESULT(S): According to this work, the positions resistant to mutation are identified. CONCLUSION(S): Based on this study, the weak linkages in AR can be identified and can be good information for the prediction of possible new mutations that can result in phenotype abnormality. In addition, the results from this study can be good information for further research on the diagnosis for AR abnormalities and new treatment.
Assuntos
Mapeamento Cromossômico , Mutação , Receptores Androgênicos/genética , Sequência de Aminoácidos , Biologia Computacional , Eletroforese em Gel Bidimensional , Genoma , Humanos , Dados de Sequência Molecular , Fragmentos de Peptídeos/química , Proteoma , Receptores Androgênicos/química , Receptores Androgênicos/isolamento & purificaçãoRESUMO
The ligand-binding domain of the human androgen receptor has been cloned, overproduced and crystallized in the presence of a coactivator-like 11-mer peptide and two different nonsteroidal ligands. The crystals of the two ternary complexes were isomorphous and belonged to space group P2(1)2(1)2(1), with one molecule in the asymmetric unit. They diffracted to 1.7 and 1.95 A resolution, respectively. Structure determination of these two complexes will help in understanding the mode of binding of selective nonsteroidal androgens versus endogenous steroidal ligands and possibly the origin of their tissue selectivity.
Assuntos
Peptídeos/metabolismo , Receptores Androgênicos/química , Sítios de Ligação , Cristalização , Cristalografia por Raios X , Humanos , Ligantes , Peptídeos/química , Estrutura Terciária de Proteína , Receptores Androgênicos/isolamento & purificação , Receptores Androgênicos/metabolismoRESUMO
Based on its important physical and pathological function, the androgen receptor (AR) is regarded as a significant drug target. In this report, the authors describe a novel strategy of protein chip technology to screen agonists and antagonists of AR. First, the AR ligand binding domain (AR-LBD) was expressed in Escherichia coli, purified, and then immobilized on a silane-polysaccharide surface of a protein chip. Second, the affinities of methyltestosterone (MT) and fluorescent-labeled testosterone for the AR-LBD protein chip were determined. Third, a converse strategy of the protein chip was tested to evaluate its reliability as a drug screening method. Fourth, a 10,067-compound library was screened to find new ligands of AR. From the results, the K(d) of testosterone and the IC(50) of MT are consistent with the literature (0.61 vs. 0.49 nM 2.88 vs. 3.90 nM, respectively). The Z' factor of the high-throughput screening (HTS) method was 0.76, which meets the requirement of drug screening (>0.4). Finally, 3 active ligands of AR were identified with their IC( 50) values of 3.63, 2.19, and 1.71 microM, respectively. In summary, the novel strategy of the AR-LBD protein chip was suitable for HTS at the molecular level.
Assuntos
Antagonistas de Receptores de Andrógenos , Androgênios , Avaliação Pré-Clínica de Medicamentos/métodos , Análise Serial de Proteínas , Animais , Avaliação Pré-Clínica de Medicamentos/instrumentação , Fluoresceína-5-Isotiocianato , Masculino , Metiltestosterona/metabolismo , Estrutura Terciária de Proteína , Ratos , Ratos Wistar , Receptores Androgênicos/química , Receptores Androgênicos/isolamento & purificaçãoRESUMO
In the ovarian follicles of mammals, androgens are utilized as substrates for estrogen synthesis or can act via androgen receptor (AR). Within the ovary, granulosa cells generally display the strongest immunoreactivity for AR protein. Therefore, the aim of the present study was to analyse possible changes in the intensity of AR staining in cultured mural and antral granulosa cells isolated from follicles at various stages of development. Porcine ovaries were obtained at a local slaughterhouse and the follicles were classified as small, medium and large dependently on their diameter. Isolated granulosa cells were separated into two populations, mural and antral, and then the cells were cultured during 48 h. After this time the cells were fixed and immunostained to visualize the AR. Androgen receptor immunostaining was detected in both, antral and mural granulosa cell cultures isolated from follicles at all stages of the development. In the mural granulosa cultures the immunostaining was comparatively weaker than that in the antral granulosa cells originating from all types of follicles. Our results provide immunohistochemical evidence that antral granulosa layer is the main site of AR immunoexpression.
Assuntos
Células da Granulosa/metabolismo , Folículo Ovariano/citologia , Receptores Androgênicos/isolamento & purificação , Suínos , Matadouros , Animais , Estrogênios/metabolismo , Feminino , Imuno-Histoquímica/veterinária , Folículo Ovariano/anatomia & histologia , Folículo Ovariano/metabolismo , Receptores Androgênicos/química , Receptores Androgênicos/metabolismoRESUMO
The constitutive androstane receptor (CAR) is a member of the nuclear receptor superfamily. In contrast to classical nuclear receptors, which possess small-molecule ligand-inducible activity, CAR exhibits constitutive transcriptional activity in the apparent absence of ligand. CAR is among the most important transcription factors; it coordinately regulates the expression of microsomal cytochrome P450 genes and other drug-metabolizing enzymes. The murine CAR ligand-binding domain (LBD) was coexpressed with the steroid receptor coactivator protein (SRC-1) receptor-interacting domain (RID) in Escherichia coli. The mCAR LBD subunit was purified away from SRC-1 by affinity, anion-exchange and size-exclusion chromatography, crystallized with androstenol and the structure of the complex determined by molecular replacement.
Assuntos
Androstenóis/metabolismo , Receptores Androgênicos/química , Receptores Androgênicos/metabolismo , Animais , Sítios de Ligação , Cristalografia por Raios X , Ligantes , Camundongos , Conformação Proteica , Receptores Androgênicos/isolamento & purificação , Proteínas Recombinantes/química , Proteínas Recombinantes/isolamento & purificação , Proteínas Recombinantes/metabolismoRESUMO
A series of nonsteroidal ligands were synthesized as second-generation agonists for the androgen receptor (AR). These ligands were designed to eliminate metabolic sites identified in one of our first-generation AR agonists, which was inactive in vivo due to its rapid metabolism to inactive constituents. The binding affinity of these compounds was evaluated using AR isolated from rat ventral prostate. These second-generation compounds bound the AR in a high affinity and stereoselective manner, with K(i) values ranging from about 4 to 130 nM. The ability of these ligands to stimulate AR-mediated transcriptional activation was examined in cells transfected with the human AR and a hormone-dependent luciferase reporter gene. Although some compounds were unable to stimulate AR-mediated transcription, several demonstrated activity similar to that of dihydrotestosterone (DHT, an endogenous steroidal ligand for the AR). We also evaluated the in vivo pharmacologic activity of selected compounds in castrated male rats. Three compounds were identified as selective androgen receptor modulators (SARMs), exhibiting significant anabolic activity while having only moderate to minimal androgenic activity in vivo.
Assuntos
Amidas/síntese química , Propionatos/síntese química , Receptores Androgênicos/efeitos dos fármacos , Amidas/química , Amidas/farmacologia , Anabolizantes/síntese química , Anabolizantes/química , Anabolizantes/farmacologia , Androgênios , Animais , Ligação Competitiva , Genes Reporter , Humanos , Ligantes , Luciferases/biossíntese , Luciferases/genética , Masculino , Orquiectomia , Propionatos/química , Propionatos/farmacologia , Próstata/química , Ratos , Receptores Androgênicos/isolamento & purificação , Estereoisomerismo , Relação Estrutura-Atividade , Transcrição GênicaRESUMO
Many studies suggest that hepatocellular carcinoma (HCC) is an androgen-dependent tumor with an incidence five times higher in males, but few data are available on the androgen receptor (AR) mRNA levels in different physiological classes of human liver specimens. In this study 108 human hepatic samples have been analyzed for AR mRNA expression by a comparative RT-PCR assay. These consisted of 35 non-tumoral hepatic samples (3 normal parenchymas, 4 steatosis, 10 hepatitis, 18 cirrhosis), 38 tumoral specimens derived from uninodular and multinodular HCCs and 35 peritumoral hepatic tissues. Normalized AR mRNA levels in tumoral and peritumoral liver tissues spanned from 0 to 146% and from 7 to 125% respectively. Only in a relatively small percentage of HCCs, the levels of expression of AR mRNA were higher than in the corresponding peritumoral tissues (16% of total HCCs). Although extremely variable, the AR mRNA levels were related to histological tumoral differentiation and proved to be lower in the highly dedifferentiated HCCs as compared to the well differentiated ones. Therefore, the evaluation of AR expression in HCC patients might be relevant for the planning of clinical studies on anti-androgen therapies, which might be useful only in the cases in which a high level of AR mRNA is detected, considering the high heterogeneity of AR mRNA levels which characterizes HCC samples. It is likely that the HCCs, expressing low or undetectable levels of AR mRNA, would not benefit by the anti-androgen therapy.
Assuntos
Carcinoma Hepatocelular/metabolismo , Carcinoma Hepatocelular/patologia , RNA Mensageiro/biossíntese , Receptores Androgênicos/biossíntese , Adulto , Idoso , Diferenciação Celular , DNA/biossíntese , DNA/genética , Feminino , Humanos , Processamento de Imagem Assistida por Computador , Masculino , Pessoa de Meia-Idade , Receptores Androgênicos/isolamento & purificação , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Células Tumorais CultivadasAssuntos
Di-Hidrotestosterona/metabolismo , Receptores Androgênicos/isolamento & purificação , Proteínas Recombinantes de Fusão/isolamento & purificação , Animais , Histidina , Humanos , Receptores Androgênicos/biossíntese , Receptores Androgênicos/genética , Proteínas Recombinantes de Fusão/biossíntese , Proteínas Recombinantes de Fusão/genéticaRESUMO
The ligand-binding domain (LBD) of the human androgen receptor (hAR LBD), encompassing amino acids (AAs) 647-919, was expressed in Escherichia coli with an N-terminal polyhistidine tag (His(10)-hAR LBD) from a pET-16b vector. The overexpressed protein was initially insoluble in inclusion bodies, and was subsequently solubilized in 8 M guanidine hydrochloride (GdnHCl). The solubilized His(10)-hAR LBD was purified to apparent homogeneity by metal ion affinity chromatography in the presence of 6 M GdnHCl. The isolated protein migrated as a single band in sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) with an apparent molecular mass of 33-34 kDa, as expected from the plasmid construct. Immunoblot analysis with C-terminal antibodies raised against a peptide corresponding to the last 19 AAs (AAs 901-919) of hAR revealed that the purified protein contained an immunoreactive epitope present within the AR and was of the appropriate size. Further characterization, using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI/TOF-MS), showed a single protein species of average mass 34 580 Da, confirming the size and purity of the purified His(10)-hAR LBD. Detailed tryptic peptide mapping analysis, using MALDI/TOF-MS, identified a total of eight peptides with a 30% coverage of the LBD, including the last tryptic peptide in the hAR sequence. These data confirm that the purified protein was the intact hAR LBD. AA sequencing of these tryptic peptides, using an HPLC-coupled electrospray ionization ion trap mass spectrometer (LC/ESI-ITMS and MS/MS), unambiguously confirmed that the peptides were from the hAR LBD. The purified His(10)-hAR LBD in 6 M GdnHCl could be renatured as determined by ligand-binding activity, with a similar equilibrium dissociation constant (K(d)) for [(3)H]-mibolerone and a similar steroid specificity to the AR isolated from rat ventral prostate.
Assuntos
Nandrolona/farmacocinética , Receptores Androgênicos/química , Receptores Androgênicos/metabolismo , Sequência de Aminoácidos , Sítios de Ligação , Cromatografia de Afinidade , Clonagem Molecular , Escherichia coli , Guanidina/química , Humanos , Cinética , Ligantes , Espectrometria de Massas , Dados de Sequência Molecular , Nandrolona/análogos & derivados , Fragmentos de Peptídeos/química , Receptores Androgênicos/isolamento & purificação , Proteínas Recombinantes/química , Proteínas Recombinantes/isolamento & purificação , Proteínas Recombinantes/metabolismo , Espectrometria de Massas por Ionização por Electrospray , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz , Trítio , TripsinaRESUMO
A full-length human androgen receptor (hAR) cDNA was used to produce recombinant baculovirus. Spodoptera frugiperda (Sf9) cells infected with this virus expressed protein with an N-terminal hexahistidine tag (His(6)-hAR) in soluble and insoluble forms. The soluble cytosolic His(6)-hAR demonstrated similar association and dissociation half-times for mibolerone, similar binding affinity for mibolerone, and similar steroid specificity as bona fide AR. Under native conditions, the soluble cytosolic His(6)-hAR was purified to apparent homogeneity in the presence of dihydrotestosterone, using metal ion affinity chromatography. The insoluble pellet fraction was solubilized with strong denaturant 6 M guanidine HCl, and His(6)-hAR was purified from it in the presence of 6 M guanidine HCl. Both the solubilized crude pellet fraction and the solubilized/purified His(6)-hAR could be renatured to bind mibolerone. The baculovirus system will therefore provide an efficient means for producing hAR for ligand-binding assays, as well as purifying hAR for detailed molecular analyses.
Assuntos
Receptores Androgênicos/isolamento & purificação , Animais , Baculoviridae/genética , Células Cultivadas , Cromatografia de Afinidade , Histidina/genética , Humanos , Cinética , Nandrolona/análogos & derivados , Nandrolona/metabolismo , Desnaturação Proteica , Receptores Androgênicos/genética , Receptores Androgênicos/metabolismo , Proteínas Recombinantes de Fusão/metabolismo , Spodoptera/genética , Esteroides/metabolismo , Frações Subcelulares/metabolismo , Congêneres da Testosterona/metabolismo , TransfecçãoRESUMO
A yeast genetic screening was developed to isolate androgen receptor (AR) mutants with divergent transactivation characteristics in response to hydroxyflutamide (HF), an active metabolite of flutamide used for prostate cancer treatment. Two mutants carrying the substitution C685Y or E708K were isolated and characterized. Substitution of C685Y for wild-type AR (wtAR) rendered the receptor supersensitive to androgenic activity from HF and female hormones such as 17beta-estradiol (E2) and progesterone (P). Similar effects were observed in the AR mutant, named T876AAR, isolated from LNCaP cells. Surprisingly, we found that C685YAR7, but not T876AAR7, could be activated by casodex (bicalutamide), a nonsteroidal pure antiandrogen, with an induction fold 3- to 5-fold times higher than that for wild type or T876AAR. By contrast, although replacement of E708K for wtAR showed little effect on dihydrotestosterone-mediated transactivation, E708KAR lost its transcriptional response from many other ligands. The effects of ligands on E708KAR could be controlled at the DNA-binding level owing to the finding of a significant decrease in the DNA-binding ability once E708KAR was bound to HF, E2, or P. Together, these results suggest that C685YAR can be a novel tool for assaying the androgenic activity from antiandrogens, and the mechanism revealed from E708KAR could provide a possible explanation for the partial androgen insensitivity syndrome in men with a natural E708KAR mutation.
Assuntos
Antagonistas de Androgênios/farmacologia , Flutamida/análogos & derivados , Flutamida/farmacologia , Mutagênese , Receptores Androgênicos/genética , Receptores Androgênicos/isolamento & purificação , Transcrição Gênica/efeitos dos fármacos , Sequência de Aminoácidos , Animais , Western Blotting , DNA/metabolismo , Estradiol/farmacologia , Expressão Gênica , Masculino , Dados de Sequência Molecular , Mutação Puntual , Progesterona/farmacologia , Ratos , Receptores Androgênicos/química , Saccharomyces cerevisiae/genética , Relação Estrutura-Atividade , Ativação Transcricional , TransfecçãoRESUMO
Full-length histidine-tagged, dihydrotestosterone-bound human androgen receptor (AR) was purified to homogeneity by affinity and gel-filtration chromatography for antibody production and analysis of AR dimerization and DNA binding properties. A monoclonal antibody was raised that recognized human and rat AR epitope (360)ArgAspTyrTyrAsnPheProLeuAla(368) in the NH(2)-terminal domain and slowed migration of AR-DNA complexes in mobility shift assays. AR binding to androgen response element DNA had a K(d) of 2.0 nM and a Hill coefficient of 2.1, indicating high-affinity, cooperative binding. AR solution dimerization was detected only at >/=0.2 microM AR, and DNA binding increased dimerization up to 30-fold. Slow- and fast-migrating AR-DNA complexes were detected under different reducing conditions that differed 5-fold in their dissociation rates from DNA. Treatment with the sulfhydryl oxidizing reagent diamide formed the faster migrating, slower dissociating complex, indicating it represents disulfide-linked AR dimers bound to DNA. The results indicate that high concentrations of purified AR are required for solution dimerization and that cooperative DNA binding stabilizes two dimer forms that differ in redox state.
Assuntos
Proteínas de Ligação a DNA/química , Proteínas de Ligação a DNA/metabolismo , Dissulfetos/química , Receptores Androgênicos/química , Receptores Androgênicos/metabolismo , Animais , Anticorpos Monoclonais/biossíntese , Baculoviridae/genética , Sítios de Ligação/genética , Proteínas de Ligação a DNA/genética , Di-Hidrotestosterona/metabolismo , Dimerização , Eletroforese em Gel de Poliacrilamida , Histidina/genética , Humanos , Camundongos , Oxirredução , Receptores Androgênicos/genética , Receptores Androgênicos/isolamento & purificação , Proteínas Recombinantes/imunologia , Proteínas Recombinantes/isolamento & purificação , Soluções , Spodoptera/genéticaRESUMO
Gonadal steroid hormones regulate sexually dimorphic development of brain functions and behaviors. Their nuclear receptors offer the opportunity to relate molecular events in neurons to simple instinctive mammalian behaviors. We have determined the role of estrogen receptor (ER) activation by endogenous estrogen in the development of male-typical behaviors by the use of transgenic estrogen-receptor-deficient (ERKO) mice. Surprisingly, in spite of the fact that they are infertile, ERKO mice showed normal motivation to mount females but they achieved less intromissions and virtually no ejaculations. Aggressive behaviors were dramatically reduced and male-typical offensive attacks were rarely displayed by ERKO males. Moreover, ER gene disruption demasculinized open-field behaviors. In the brain, despite the evident loss of functional ER protein, the androgen-dependent system appears to be normally present in ERKO mice. Together, these findings indicate that ER gene expression during development plays a major role in the organization of male-typical aggressive and emotional behaviors in addition to simple sexual behaviors.